BlackRock »

Krystal Biotech shares owned by BlackRock

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by BlackRock

Quarter filed Position value Share count Share price at filing
2024-12-31 $632M 4.0M 156.66
2024-09-30 $727M 4.0M 182.03

More positions owned by BlackRock

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Mastercard Incorporated Cl A (MA)

View all positions for BlackRock

Top funds holding Krystal Biotech

FMR
BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
Capital World Investors
Frazier Life Sciences Management
Redmile Group
Geode Capital Management
Dimensional Fund Advisors
Hood River Capital Management
T. Rowe Price Associates
Soleus Capital Management
Nuveen Asset Management
Jennison Associates

View all funds holding Krystal Biotech